Estrogen deficiency accelerates postmenopausal atherosclerosis by inducing endothelial cell ferroptosis through inhibiting NRF2/GPX4 pathway
- 23 May 2023
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 37 (6), e22992
- https://doi.org/10.1096/fj.202300083r
Abstract
Oxidative stress and lipid metabolism disorder caused by estrogen deficiency are regarded as the main causes of postmenopausal atherosclerosis, but the underlying mechanisms remain still unclear. In this study, ovariectomized (OVX) female ApoE(-/-) mice fed with high-fat diet were used to imitate postmenopausal atherosclerosis. The atherosclerosis progression was significantly accelerated in OVX mice, accompanied by the upregulation of ferroptosis indicators, including increased lipid peroxidation and iron deposition in the plaque and the plasma. While both estradiol (E2) and ferroptosis inhibitor ferrostatin-1 alleviated atherosclerosis in OVX mice, with the inhibition of lipid peroxidation and iron deposition, as well as the upregulation of xCT and GPX4, especially in endothelial cells. We further investigated the effects of E2 on ferroptosis in endothelial cells induced by oxidized-low-density lipoprotein or ferroptosis inducer Erastin. It was found that E2 exhibited anti-ferroptosis effect through antioxidative functions, including improving mitochondrial dysfunction and upregulating GPX4 expression. Mechanistically, NRF2 inhibition attenuated the effect of E2 against ferroptosis as well as the upregulation of GPX4. Our findings revealed that endothelial cell ferroptosis played a pivotal role in postmenopausal atherosclerosis progression, and the NRF2/GPX4 pathway activation contributed to the protection of E2 against endothelial cell ferroptosis.Keywords
Funding Information
- National Natural Science Foundation of China (82061130223, 82072031)
This publication has 53 references indexed in Scilit:
- Role of Nrf2 in the pathogenesis of atherosclerosisFree Radical Biology & Medicine, 2015
- Estrogen regulates iron homeostasis through governing hepatic hepcidin expression via an estrogen response elementGene, 2012
- Nrf2 in bone marrow-derived cells positively contributes to the advanced stage of atherosclerotic plaque formationFree Radical Biology & Medicine, 2012
- Estrogen-dependent inhibition of dextrose-induced endoplasmic reticulum stress and superoxide generation in endothelial cellsFree Radical Biology & Medicine, 2012
- Estrogen-dependent activation of neutral cholesterol ester hydrolase underlying gender difference of atherogenesis in apoE−/− miceAtherosclerosis, 2011
- Aging and estrogen alter endothelial reactivity to reactive oxygen species in coronary arteriolesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- NF-E2–Related Factor 2 Promotes Atherosclerosis by Effects on Plasma Lipoproteins and Cholesterol Transport That Overshadow Antioxidant ProtectionArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Endothelial Estrogen Receptor-α Plays a Crucial Role in the Atheroprotective Action of 17β-Estradiol in Low-Density Lipoprotein Receptor–Deficient MiceJournal of the American College of Cardiology, 2009
- Iron and Menopause: Does Increased Iron Affect the Health of Postmenopausal Women?Antioxidants and Redox Signaling, 2009
- Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys.JCI Insight, 1991